Financings Of The Fortnight: Exelixis Follows Horrible Year With Successful Stock Offering
This article was originally published in The Pink Sheet Daily
Executive Summary
News on recent financings by Aerie Pharmaceuticals, Nimbus Discovery, BioCryst and Omthera Pharmaceuticals.